Epigenomics AG / Key word(s): Capital Increase 16.11.2016 15:13 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares […]
Category: Insider Information
07. November 2016
Epigenomics AG issues new shares by way of private placement
Epigenomics AG / Key word(s): Capital Increase 07.11.2016 18:50 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Publication of Inside Information according to Article 17 MAR Epigenomics AG issues new shares […]
30. June 2016
Supervisory Board of Epigenomics AG appoints Gregory Hamilton as Chief Executive Officer (CEO)
Epigenomics AG / Key word(s): Change of Personnel 30.06.2016 21:17 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Supervisory […]
24. May 2016
Epigenomics AG issues new shares by way of private placement
Epigenomics AG / Key word(s): Capital Increase 24.05.2016 17:56 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad Hoc Announcement Pursuant to §15 WpHG (German Securities Trading Act) Epigenomics AG […]
13. April 2016
Epigenomics receives FDA approval for Epi proColon(R)
Epigenomics AG / Key word(s): Regulatory Approval 13.04.2016 08:06 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Ad-hoc release Epigenomics receives FDA approval for Epi proColon(R) Berlin (Germany) and Germantown, […]
30. March 2016
Epigenomics AG: Epigenomics enters strategic license and development agreement with BioChain on novel, blood-based lung cancer test for China
Epigenomics AG / Key word(s): Agreement 30.03.2016 09:02 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Epigenomics enters strategic license and development agreement with BioChain on novel, blood-based lung cancer […]